Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Eyes and Ocular Pathology”

383 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 383 results

Not applicableStudy completedNCT03852485
What this trial is testing

Comparison of OCT and OCTA-based Ocular Measurements to Those of Predicate

Who this might be right for
Normal Eyes and Eyes With Ocular Pathologies
Optovue 199
Testing effectiveness (Phase 2)Study completedNCT00062933
What this trial is testing

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT00007215
What this trial is testing

Dynamic Light Scattering Device (DLS) Study of Age-Related Changes in the Lens and Cataracts

Who this might be right for
CataractHealthy
National Eye Institute (NEI) 24
Not applicableStudy completedNCT00086476
What this trial is testing

Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles

Who this might be right for
Blood Coagulation Disorders
National Human Genome Research Institute (NHGRI) 3
Testing effectiveness (Phase 2)Study completedNCT01257750
What this trial is testing

Treatment of Corneal Neovascularization With Topical Pazopanib

Who this might be right for
Corneal Neovascularization
Reza Dana, MD 20
Testing effectiveness (Phase 2)Study completedNCT01838655
What this trial is testing

Nitisinone for Type 1B Oculocutaneous Albinism

Who this might be right for
AlbinismVision Loss
National Eye Institute (NEI) 5
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Early research (Phase 1)Looking for participantsNCT06371417
What this trial is testing

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Very early researchWithdrawnNCT06548620
What this trial is testing

RD06-04 in Patients With Active Autoimmune Diseases

Who this might be right for
SLESclerosisANCA Associated Vasculitis+5 more
Nanjing Bioheng Biotech Co., Ltd.
Not applicableLooking for participantsNCT07355491
What this trial is testing

Performance Evaluation of Dream OCT: AP Study

Who this might be right for
Glaucoma PatientsRetina PatientsEyes With Corneal Abnormality+1 more
Intalight, Inc 120
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01211977
What this trial is testing

A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease

Who this might be right for
Muckle Wells SyndromeAutoinflammatoryBehcet's Disease
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Testing effectiveness (Phase 2)Study completedNCT00867529
What this trial is testing

Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+35 more
Fred Hutchinson Cancer Center 63
Not applicableNot Yet RecruitingNCT06875102
What this trial is testing

Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies

Who this might be right for
Sjogren Syndrome
Centre Hospitalier Universitaire de Saint Etienne 174
Not applicableStudy completedNCT00782366
What this trial is testing

Predictive Genetic Risk Assessment Trial

Who this might be right for
Colon CancerLung CancerAtrial Fibrillation+8 more
Mayo Clinic 26
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT04802577
What this trial is testing

Fatigue in Primary Sjögren's Syndrome

Who this might be right for
Sjogren's SyndromeFatiguePain Syndrome+3 more
Bursa Yuksek Ihtisas Training and Research Hospital 110
Not applicableNot Yet RecruitingNCT06271005
What this trial is testing

Neurological Dry Eye Study Stimulating Both Lacrimal and Vagus Nerves

Who this might be right for
Dry Eye DiseaseDry Eye
Genetic Disease Investigators 75
Early research (Phase 1)Ended earlyNCT01643603
What this trial is testing

Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more
Barbara Ann Karmanos Cancer Institute 5
Load More Results